Atlas Trials

Safety Study of A-101 Topical Solution for the Treatment of Common Warts

Clinical trial NCT03812510 · COMPLETED

Trial details

NCT number
NCT03812510
Sponsor
Aclaris Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Common Wart
Start date
2019-02-07
Primary completion
2019-11-27
Enrollment
426

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.